Should Partners of Women with Bacterial Vaginosis be Treated?

While initial cure rates for bacterial vaginosis (BV) approach 80%, 2 out of 3 women experience a recurrence within 6 months of treatment. Since BV is not currently considered a sexually transmitted infection, treatment guidelines do not include treating partners of women with BV. How does this approach to management align with epidemiologic data and current trial results?

In this supplement, Christina Muzny, MD, MSPH examines the issue of BV re-infection and partner treatment, to include:

• Prevalence and associated complications of BV

• Current CDC STD Treatment Guidelines

• Epidemiologic data that supports the sexual transmission of BV

• Methodological shortcomings of prior partner treatment trials

Read this supplement to learn more about treating partners of women with BV.

Supported by:

Lupin Pharmaceuticals